On 2026-10-07, Truist raised its GILD price target to $158 from $150 (+5.3%).
Truist 于 2026-10-07 将 GILD 目标价上调至 $158，此前为 $150，变动幅度 +5.3%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
HSBC raises GILD target to $175 from $155HSBC 上调目标价 吉利德 (GILD)：$155 → $175
Rating Change · September 10, 2026评级变动 · 2026/9/10
GILD regulatory decision: FDA approves daily HIV pill from Gilead designed to simplify treatment for some patientsGilead Sciences, Inc.（GILD）的 产品 获美国 FDA 许可或批准
Material Company Event · August 27, 2026公司公告 · 2026/8/27
GILD earnings call: guidance, demand, margins, analyst Q&AGilead Sciences, Inc. (GILD) 电话会要点：指引、需求、利润率、分析师问答
Earnings Analysis · August 5, 2026财报电话会 · 2026/8/5
